We are live on ! Find out more
CSIC

Clifford Swan Investment Counsel Portfolio holdings

AUM $2.94B
1-Year Est. Return 21.31%
This Fund
S&P 500
This Quarter Est. Return
+21.25%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$1.94B
AUM Growth
+$298M
Cap. Flow
-$8.3M
Cap. Flow %
-0.43%
Top 10 Hldgs %
27.85%
Holding
317
New
17
Increased
75
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$4.69M
2
RTX icon
RTX Corp
RTX
+$4.34M
3
PYPL icon
PayPal
PYPL
+$2.64M
4
AAPL icon
Apple
AAPL
+$2.48M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$1.93M

Sector Composition

Rank Sector Weight
1 Technology 23.08%
2 Healthcare 15.36%
3 Industrials 13.59%
4 Consumer Staples 10.03%
5 Consumer Discretionary 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERN
51
DELISTED
Cerner Corp
CERN
$11.8M 0.61%
172,247
+2,510
+1% +$172K
CTVA icon
52
Corteva
CTVA
$50.4B
$11.7M 0.6%
437,977
+17,080
+4% +$444K
EBAY icon
53
eBay
EBAY
$45.5B
$11.3M 0.58%
215,071
+167
+0.1% +$7.06K
BNY
54
Bank of New York Mellon
BNY
$111B
$11.2M 0.58%
289,983
-24,525
-8% -$897K
SYY icon
55
Sysco
SYY
$40.5B
$11.2M 0.57%
204,481
-10,629
-5% -$559K
MMM icon
56
3M
MMM
$94.8B
$11.1M 0.57%
84,932
-1,044
-1% -$132K
HON icon
57
Honeywell
HON
$74.6B
$10.8M 0.55%
79,054
HPE icon
58
Hewlett Packard
HPE
$77.8B
$10.7M 0.55%
1,097,538
+14,900
+1% +$146K
VZ icon
59
Verizon
VZ
$195B
$10.6M 0.54%
191,798
-1,864
-1% -$105K
UNH icon
60
UnitedHealth
UNH
$364B
$10.5M 0.54%
35,755
+486
+1% +$139K
RTX icon
61
RTX Corp
RTX
$300B
$10.5M 0.54%
170,391
-69,600
-29% -$4.34M
AXP icon
62
American Express
AXP
$232B
$10.3M 0.53%
107,813
+10,328
+11% +$951K
MCK icon
63
McKesson
MCK
$102B
$10.1M 0.52%
65,813
+1,500
+2% +$217K
ENR icon
64
Energizer
ENR
$1.56B
$9.92M 0.51%
208,906
WMT icon
65
Walmart Inc
WMT
$923B
$9.91M 0.51%
248,280
-14,070
-5% -$579K
LH icon
66
Labcorp
LH
$26.2B
$9.57M 0.49%
67,086
+5,785
+9% +$800K
KEYS icon
67
Keysight
KEYS
$60.6B
$9.53M 0.49%
94,593
-100
-0.1% -$9.82K
ADP icon
68
Automatic Data Processing
ADP
$107B
$9.53M 0.49%
64,017
-425
-0.7% -$60.9K
JCI icon
69
Johnson Controls International
JCI
$92.6B
$9.46M 0.49%
277,029
-6,657
-2% -$205K
SBUX icon
70
Starbucks
SBUX
$124B
$9.01M 0.46%
122,406
+9,888
+9% +$743K
NVS icon
71
Novartis
NVS
$290B
$9M 0.46%
103,040
-2,054
-2% -$177K
VCSH icon
72
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$8.77M 0.45%
106,105
+3,717
+4% +$302K
PM icon
73
Philip Morris
PM
$290B
$8.64M 0.44%
123,376
-100
-0.1% -$7.29K
COP icon
74
ConocoPhillips
COP
$153B
$8.44M 0.43%
200,956
-12,102
-6% -$489K
NVO
75
Novo Nordisk
NVO
$203B
$8.17M 0.42%
249,494
-5,166
-2% -$165K

Similar funds

Clifford Swan Investment Counsel's Q2 2020 Portfolio in Review

As of Q2 2020, Clifford Swan Investment Counsel held 317 positions worth $1.94B, up 18% from $1.65B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Clifford Swan Investment Counsel's Q2 2020 filing shows 17 new, 75 increased, 115 reduced and 8 closed positions. Its largest new stake was Otis Worldwide: 67,424 shares worth $3.83M. The largest sale was Allergan plc, an estimated $4.69M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Clifford Swan Investment Counsel's largest Q2 2020 buy was Otis Worldwide: 67,424 shares worth $3.83M.
  • Clifford Swan Investment Counsel added most to First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF in Q2 2020, an estimated $4.05M increase.
  • Clifford Swan Investment Counsel's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $4.34M.
  • Clifford Swan Investment Counsel fully exited Allergan plc in Q2 2020, selling an estimated $4.69M.
  • Clifford Swan Investment Counsel's ten largest holdings make up 28% of its $1.94B portfolio in Q2 2020.
  • Clifford Swan Investment Counsel opened 17 new positions and closed 8 in Q2 2020.
  • Clifford Swan Investment Counsel's portfolio value rose 18% quarter-over-quarter to $1.94B.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2020, filed 6 Aug 2020.